Aprotinin

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Aprotinin belongs to the group of antifibrinolytics and is a protease inhibitor consisting of 58 amino acids, which is cross-linked as a single-chain polypeptide via 3 disulfide bridges. Aprotinin is mainly extracted from the bovine lung. Aprotinin is also available in recombinant form.

It is a non-specific protein that inhibits serine proteases, trypsin, kallikrein, plasmin and antitrypsin. In addition to the effects mentioned above, it inhibits the thrombolytic action of streptokinase, the tissue plasminogen activator (tPA) and urokinase.

IndicationThis section has been translated automatically.

Hyperfibrinolytic hemostasis disorders, in case of traumatic hemorrhagic shock and bleeding complications during thrombolytic therapy.

PreparationsThis section has been translated automatically.

Trasylol® or Antagosan®

LiteratureThis section has been translated automatically.

  1. HA Neumann (2014) The coagulation system. ABW-Scientific Publisher GmbH Berlin

Authors

Last updated on: 29.10.2020